Psychometric properties of patient-reported outcome measures, measuring fatigue in patients with multiple sclerosis, a systematic review

IF 2.9 3区 医学 Q2 CLINICAL NEUROLOGY Multiple sclerosis and related disorders Pub Date : 2024-11-14 DOI:10.1016/j.msard.2024.106169
Miguel Angel Jorquera Ruzzi , Martí Boix Coll , María Jose Dura Mata , María Cristina Ramo Tello , Irma Casas García
{"title":"Psychometric properties of patient-reported outcome measures, measuring fatigue in patients with multiple sclerosis, a systematic review","authors":"Miguel Angel Jorquera Ruzzi ,&nbsp;Martí Boix Coll ,&nbsp;María Jose Dura Mata ,&nbsp;María Cristina Ramo Tello ,&nbsp;Irma Casas García","doi":"10.1016/j.msard.2024.106169","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Multiple sclerosis (MS) is a chronic, inflammatory, degenerative disease of the central nervous system. One of the most common and disabling symptoms is fatigue. More than 80% of people with MS experience fatigue, which has a negative impact on their quality of life and level of independence in daily activities. The multidimensional nature of fatigue makes it essential to understand its impact from the patient's perspective. Patient-reported outcomes (PROs), defined by the FDA as \"any report of a patient's health status that comes directly from the patient, without interpretation of the patient's response by the physician or other health care professional,\" were created to address this need.</div></div><div><h3>Objectives</h3><div>To identify and describe patient-reported outcomes (PROs) that measure the level of fatigue specific to patients with multiple sclerosis.</div><div>To evaluate and analyze the quality of psychometric properties, methodological quality, and risk of bias of patient-reported outcomes that measure the level of fatigue specific to patients with multiple sclerosis.</div></div><div><h3>Methods</h3><div>A systematic psychometric review was conducted and framed according to the standards of the Consensus for the Selection of Measurement Instruments (COSMIN) (Mokkink et al., 2010).</div></div><div><h3>Results</h3><div>A total of 34 studies were included, from which a total of 40 references were extracted, as some studies reported two or more PROMs simultaneously. The evaluation and analysis of the risk of bias shows that the studies present a heterogeneous classification depending on the psychometric property evaluated, i.e. while the frequency of studies classified with low risk of bias is higher in measurement properties such as; structural validity; 25 studies (64.10%), internal consistency 25 studies (64.10%), criterion validity: 29 studies (74.36%). There is also a high frequency of studies rated as high or unclear risk of bias, mainly in psychometric properties such as reliability 19 studies (48.71%), cross-cultural validity measurement invariance 13 studies (33.33%).</div></div><div><h3>Conclusions</h3><div>PRO instruments are the best way to know the patients' perception of their symptomatology in this case of fatigue, which will undoubtedly contribute to a better approach and better intervention strategies in a personalized way, another component in the improvement of the quality of care and in line with the new paradigm of patient-centered care, which requires an assessment of fatigue by means of a PRO instrument. Therefore, it is of utmost importance to consider the current standards in the development of these instruments for a correct use and interpretability of their results.</div></div>","PeriodicalId":18958,"journal":{"name":"Multiple sclerosis and related disorders","volume":"92 ","pages":"Article 106169"},"PeriodicalIF":2.9000,"publicationDate":"2024-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Multiple sclerosis and related disorders","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2211034824007454","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Multiple sclerosis (MS) is a chronic, inflammatory, degenerative disease of the central nervous system. One of the most common and disabling symptoms is fatigue. More than 80% of people with MS experience fatigue, which has a negative impact on their quality of life and level of independence in daily activities. The multidimensional nature of fatigue makes it essential to understand its impact from the patient's perspective. Patient-reported outcomes (PROs), defined by the FDA as "any report of a patient's health status that comes directly from the patient, without interpretation of the patient's response by the physician or other health care professional," were created to address this need.

Objectives

To identify and describe patient-reported outcomes (PROs) that measure the level of fatigue specific to patients with multiple sclerosis.
To evaluate and analyze the quality of psychometric properties, methodological quality, and risk of bias of patient-reported outcomes that measure the level of fatigue specific to patients with multiple sclerosis.

Methods

A systematic psychometric review was conducted and framed according to the standards of the Consensus for the Selection of Measurement Instruments (COSMIN) (Mokkink et al., 2010).

Results

A total of 34 studies were included, from which a total of 40 references were extracted, as some studies reported two or more PROMs simultaneously. The evaluation and analysis of the risk of bias shows that the studies present a heterogeneous classification depending on the psychometric property evaluated, i.e. while the frequency of studies classified with low risk of bias is higher in measurement properties such as; structural validity; 25 studies (64.10%), internal consistency 25 studies (64.10%), criterion validity: 29 studies (74.36%). There is also a high frequency of studies rated as high or unclear risk of bias, mainly in psychometric properties such as reliability 19 studies (48.71%), cross-cultural validity measurement invariance 13 studies (33.33%).

Conclusions

PRO instruments are the best way to know the patients' perception of their symptomatology in this case of fatigue, which will undoubtedly contribute to a better approach and better intervention strategies in a personalized way, another component in the improvement of the quality of care and in line with the new paradigm of patient-centered care, which requires an assessment of fatigue by means of a PRO instrument. Therefore, it is of utmost importance to consider the current standards in the development of these instruments for a correct use and interpretability of their results.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
患者报告的结果测量的心理计量特性,多发性硬化症患者的疲劳测量,系统综述。
背景:多发性硬化症(MS)是一种慢性、炎症性、中枢神经系统退行性疾病。疲劳是最常见的致残性症状之一。80% 以上的多发性硬化症患者都会感到疲劳,这对他们的生活质量和日常活动的独立性产生了负面影响。疲劳的多面性使得从患者的角度了解其影响至关重要。患者报告结果(PROs)被美国食品药品管理局定义为 "任何直接来自患者的健康状况报告,而不需要医生或其他医疗保健专业人员对患者的反应进行解释":确定并描述可测量多发性硬化症患者疲劳程度的患者报告结果(PROs)。评估和分析测量多发性硬化症患者疲劳程度的患者报告结果的心理测量学特性、方法学质量和偏倚风险:根据测量工具选择共识(COSMIN)(Mokkink 等人,2010 年)的标准进行了系统的心理测量学回顾:结果:共纳入 34 项研究,从中提取了 40 篇参考文献,因为有些研究同时报告了两种或两种以上的 PROMs。对偏倚风险的评估和分析表明,根据所评估的心理测量学特性,这些研究呈现出不同的分类,即偏倚风险较低的研究在测量特性方面的频率较高,如结构有效性:25 项研究(64.10%)、内部一致性:25 项研究(64.10%)、标准有效性:29 项研究(74.36%)。被评为偏倚风险高或不明确的研究也很常见,主要是心理测量学特性,如可靠性 19 项研究(48.71%)、跨文化有效性测量不变性 13 项研究(33.33%):PRO工具是了解患者对其疲劳症状看法的最佳途径,这无疑有助于以个性化的方式采取更好的方法和更好的干预策略,是提高护理质量的另一个组成部分,也符合以患者为中心的护理新模式,即需要通过PRO工具对疲劳进行评估。因此,最重要的是在开发这些工具时要考虑到当前的标准,以便正确使用和解释其结果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
5.80
自引率
20.00%
发文量
814
审稿时长
66 days
期刊介绍: Multiple Sclerosis is an area of ever expanding research and escalating publications. Multiple Sclerosis and Related Disorders is a wide ranging international journal supported by key researchers from all neuroscience domains that focus on MS and associated disease of the central nervous system. The primary aim of this new journal is the rapid publication of high quality original research in the field. Important secondary aims will be timely updates and editorials on important scientific and clinical care advances, controversies in the field, and invited opinion articles from current thought leaders on topical issues. One section of the journal will focus on teaching, written to enhance the practice of community and academic neurologists involved in the care of MS patients. Summaries of key articles written for a lay audience will be provided as an on-line resource. A team of four chief editors is supported by leading section editors who will commission and appraise original and review articles concerning: clinical neurology, neuroimaging, neuropathology, neuroepidemiology, therapeutics, genetics / transcriptomics, experimental models, neuroimmunology, biomarkers, neuropsychology, neurorehabilitation, measurement scales, teaching, neuroethics and lay communication.
期刊最新文献
Strength training attenuates neuropathic pain by Preventing dendritic Spine dysgenesis through Suppressing Rac1 and inflammation in experimental autoimmune encephalomyelitis Adaptation, construct validity, and test-retest reliability of the Cognitive Reserve Index Questionnaire for the Israeli multiple sclerosis population Incorporation of the central vein sign into the McDonald criteria Hypogammaglobulinemia and severe infections in Multiple Sclerosis patients on anti-CD20 agents: A multicentre study Curriculum innovation: Interactive educational workshop improves neurology resident knowledge of multiple sclerosis
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1